Zobrazeno 1 - 10
of 236
pro vyhledávání: '"tumor infiltrating immune cell"'
Autor:
Lupeng Qiu, Zizhong Yang, Guhe Jia, Yanjie Liang, Sicheng Du, Jian Zhang, Minglu Liu, Xiao Zhao, Shunchang Jiao
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e33109- (2024)
Tumor-infiltrating immune cells (TICs) play a central role in the tumor microenvironment, which can reflect the host anti-tumor immune response. However, few studies have explored TICs in predicting the prognosis of lung adenocarcinoma (LUAD). In our
Externí odkaz:
https://doaj.org/article/cb20cfd5f1bc4edf8f30d556d97cbfa5
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
Externí odkaz:
https://doaj.org/article/ee338860fd10430a958559bc1a3c15a8
Publikováno v:
Biochemistry and Biophysics Reports, Vol 36, Iss , Pp 101557- (2023)
Tumor-infiltrating immune cells (TICs) affect tumorigenesis and tumor development in head and neck squamous cell carcinoma (HNSCC). We constructed a novel predictive model for HNSCC based on immune-related genes (IRGs) from The Cancer Genome Atlas an
Externí odkaz:
https://doaj.org/article/d242f144b8964d97b98c4c57cbe110bb
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-22 (2023)
Abstract Background STIL centriolar assembly protein (STIL) is a cytoplasmic protein implicated in cellular growth and proliferation as well as chromosomal stability, which abnormal condition affected tumor immunity and tumor progression. However, th
Externí odkaz:
https://doaj.org/article/96a4913c69184516bb343f65a9ec0d88
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Laryngeal squamous cell carcinoma (LSCC) is the most common squamous cell carcinoma. Though significant effort has been focused on molecular pathogenesis, development, and recurrence of LSCC, little is known about its relationship
Externí odkaz:
https://doaj.org/article/dd1209458acc46bdb41a6f8e957a9b3f
Autor:
Zhenghang Wang, Xinyu Wang, Yu Xu, Jian Li, Xiaotian Zhang, Zhi Peng, Yajie Hu, Xinya Zhao, Kun Dong, Bei Zhang, Chan Gao, Xiaochen Zhao, Hui Chen, Jinping Cai, Yuezong Bai, Yu Sun, Lin Shen
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background A significant subset of mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) gastric adenocarcinomas (GAC) are resistant to immune checkpoint inhibitors (ICIs), yet the underlying mechanism remains largely unkn
Externí odkaz:
https://doaj.org/article/a78e631447fb4ae89f9a47b6ed404f64
Autor:
Sicheng Liu, Xingyu Peng, Xun Wu, Fanqin Bu, Zhonglin Yu, Jinfeng Zhu, Chen Luo, Wenjun Zhang, Jiang Liu, Jun Huang
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background An increasing number of studies have shown that immune-related long noncoding RNAs (lncRNAs) do not require a unique expression level. This finding may help predict the survival and drug sensitivity of patients with colon cancer.
Externí odkaz:
https://doaj.org/article/0d705eff586c4ef783422f118b06b535
Autor:
Xiaoming Wang, Yunjin Bai, Facai Zhang, Dengxiong Li, Kai Chen, Ruicheng Wu, Yin Tang, Xin Wei, Ping Han
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionBladder cancer (BLCA) is one of the most lethal diseases. COL10A1 is secreted small-chain collagen in the extracellular matrix associated with various tumors, including gastric, colon, breast, and lung cancer. However, the role of COL10A1
Externí odkaz:
https://doaj.org/article/0b2ce84ded2143c5bdfa346a8a1790b4
Autor:
Mingjia Li, Xinrui Long, Wenbo Bu, Guanxiong Zhang, Guangtong Deng, Yuancheng Liu, Juan Su, Kai Huang
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundMelanoma is among the most malignant immunologic tumor types and is associated with high mortality. However, a considerable number of melanoma patients cannot benefit from immunotherapy owing to individual differences. This study attempts t
Externí odkaz:
https://doaj.org/article/df634a6c677d4f9f88988c7ff34a285f
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionWe aimed to develop a copper-related gene (CRG) signature that can be used to evaluate prognosis and guide therapeutic management in bladder cancer patients.MethodsThe raw transcriptome profiles and clinical data of 405 bladder samples we
Externí odkaz:
https://doaj.org/article/b68104bd42fa4587aae038f21a555ff2